Patel Tushar Bhikhubhai's Form 4 filing
Amneal Pharmaceuticals, Inc. (AMRX) · filed Mar 17, 2025
- Accession no.
- 0000898432-25-000191
- Filed
- Mar 17, 2025
- Trade date
- Mar 14, 2025
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market sales total $41.8M. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Patel Tushar BhikhubhaiCIK 0001745375 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 14, 2025 | Class A Common Stock | SSaleDisposed | −5,000,000 | $8.35 | −$41,750,000 | 48,578,209 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.